Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Hoag Hospital Clinical Study Demonstrates Luna Reduces Post-surgical Rehab Costs by 52%

In a groundbreaking study, Hoag Hospital, a leading not-for-profit regional health care delivery network in Orange County, California, presented the results of a two-year analysis at the 2023 American Association of Orthopedic Executives (AAOE) conference. The study demonstrated that the Luna in-home outpatient physical therapy care model reduces costs by 52% compared with traditional home health for total knee and hip replacements.

Hoag Orthopedic Institute conducted the study between 2021 and 2023 in collaboration with Luna, the leading provider of in-home outpatient physical therapy, to create a scalable solution aimed at reducing per episode care costs through the use of in-home outpatient physical therapy in lieu of traditional home health services. The complete study can be viewed here.

As healthcare spending continues to rise, the American Academy of Orthopaedic Surgeons forecast a substantial increase in total knee replacement or total hip replacement surgery, with projected growth rates of up to 171% and 189% respectively (source) by 2030.

The Hoag Orthopedic Institute study showed that with the Luna care model, participating surgeons reduced their home health utilization by 86%, resulting in decreased blended costs of $2,517 per case. Patient outcomes also improved as readmission rates were reduced by 28%, compared with patients that received the traditional home health option.

Patients also demonstrated clinically important changes in pain and patient-specific functional scale scores of 66% and 76% respectively, and rated Luna with a world-class net promoter score of 89.

“Luna’s care model is cost-effective and leads to better patient outcomes when compared with traditional home health, and is revolutionizing healthcare delivery nationwide. By making high-quality care more accessible to patients, Luna can provide postoperative total hip replacement and total knee replacement patients with a more efficient alternative to traditional home health services,” said Palak Shah, Co-Founder and Head of Clinical Operations at Luna.

At Hoag, overutilization of home health visits was also a challenge, with patients utilizing an average of eight visits of home health prior to continuing care at an outpatient facility. While a typical course of care at Luna consists of completing the entire care plan with a Luna therapist (all billed under outpatient rates, and delivered to the home), Hoag had patients complete the initial four to six treatment sessions with Luna prior to transitioning to an outpatient facility.

Patients completed four visits for total hip replacements and six visits for total knee replacements with the Luna therapist. During care at Luna, patients were monitored for visit utilization, post-surgical complications, readmissions, and adverse outcomes.

Innovative healthcare organizations are exploring cost-effective ways of delivering care while continuing to improve patient outcomes, and, to date, Luna has collaborated with Providence, Emory Healthcare, Intermountain Healthcare, UCLA Health and Scripps Health, among others.

Luna currently operates across 48 markets in 27 states, and has treated 35,000+ patients in their homes. In 2022, Luna became the fastest growing physical therapy clinic nationally with 6,183 percent growth in visits during the four consecutive years since it was founded in 2018. This is higher than any reported growth during the same time frame from any physical therapy clinic group.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy